These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 25225801)
1. Large variations in risk of hepatocellular carcinoma and mortality in treatment naïve hepatitis B patients: systematic review with meta-analyses. Thiele M; Gluud LL; Fialla AD; Dahl EK; Krag A PLoS One; 2014; 9(9):e107177. PubMed ID: 25225801 [TBL] [Abstract][Full Text] [Related]
2. Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan. Chen TH; Chen CJ; Yen MF; Lu SN; Sun CA; Huang GT; Yang PM; Lee HS; Duffy SW Int J Cancer; 2002 Mar; 98(2):257-61. PubMed ID: 11857416 [TBL] [Abstract][Full Text] [Related]
3. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690 [TBL] [Abstract][Full Text] [Related]
4. Incidence of hepatocellular carcinoma in untreated subjects with chronic hepatitis B: a systematic review and meta-analysis. Raffetti E; Fattovich G; Donato F Liver Int; 2016 Sep; 36(9):1239-51. PubMed ID: 27062182 [TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Fattovich G; Stroffolini T; Zagni I; Donato F Gastroenterology; 2004 Nov; 127(5 Suppl 1):S35-50. PubMed ID: 15508101 [TBL] [Abstract][Full Text] [Related]
6. Demographics and outcomes of hepatitis B and D: A 10-year retrospective analysis in a Swiss tertiary referral center. Vieira Barbosa J; Sahli R; Aubert V; Chaouch A; Moradpour D; Fraga M PLoS One; 2021; 16(4):e0250347. PubMed ID: 33905426 [TBL] [Abstract][Full Text] [Related]
7. Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules. Mariño Z; Darnell A; Lens S; Sapena V; Díaz A; Belmonte E; Perelló C; Calleja JL; Varela M; Rodriguez M; Rodriguez de Lope C; Llerena S; Torras X; Gallego A; Sala M; Morillas RM; Minguez B; Llaneras J; Coll S; Carrion JA; Iñarrairaegui M; Sangro B; Vilana R; Sole M; Ayuso C; Ríos J; Forns X; Bruix J; Reig M J Hepatol; 2019 May; 70(5):874-884. PubMed ID: 30684506 [TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma prediction beyond year 5 of oral therapy in a large cohort of Caucasian patients with chronic hepatitis B. Papatheodoridis GV; Sypsa V; Dalekos GN; Yurdaydin C; Van Boemmel F; Buti M; Calleja JL; Chi H; Goulis J; Manolakopoulos S; Loglio A; Voulgaris T; Gatselis N; Keskin O; Veelken R; Lopez-Gomez M; Hansen BE; Savvidou S; Kourikou A; Vlachogiannakos J; Galanis K; Idilman R; Esteban R; Janssen HLA; Berg T; Lampertico P J Hepatol; 2020 Jun; 72(6):1088-1096. PubMed ID: 31981727 [TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma among US and non-US-born patients with chronic hepatitis B: Risk factors and age at diagnosis. Kennedy K; Graham SM; Arora N; Shuhart MC; Kim HN PLoS One; 2018; 13(9):e0204031. PubMed ID: 30252863 [TBL] [Abstract][Full Text] [Related]
10. Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis. Lin CW; Lin CC; Mo LR; Chang CY; Perng DS; Hsu CC; Lo GH; Chen YS; Yen YC; Hu JT; Yu ML; Lee PH; Lin JT; Yang SS J Hepatol; 2013 Apr; 58(4):730-5. PubMed ID: 23220252 [TBL] [Abstract][Full Text] [Related]
11. Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: a need for surveillance. Kim GA; Lee HC; Kim MJ; Ha Y; Park EJ; An J; Lee D; Shim JH; Kim KM; Lim YS J Hepatol; 2015 May; 62(5):1092-9. PubMed ID: 25445399 [TBL] [Abstract][Full Text] [Related]
12. Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia. Alavi M; Law MG; Valerio H; Grebely J; Amin J; Hajarizadeh B; Selvey C; George J; Dore GJ J Hepatol; 2019 Aug; 71(2):281-288. PubMed ID: 31078544 [TBL] [Abstract][Full Text] [Related]
13. Profile and value of FIB-4 in patients with dual chronic hepatitis C and B. Liu CJ; Tseng TC; Yang WT; Su TH; Yang HC; Liu CH; Chen PJ; Chen DS; Kao JH J Gastroenterol Hepatol; 2019 Feb; 34(2):410-417. PubMed ID: 30151861 [TBL] [Abstract][Full Text] [Related]
14. Risk factors for early-onset and late-onset hepatocellular carcinoma in Asian immigrants with hepatitis B in the United States. Wan DW; Tzimas D; Smith JA; Kim S; Araujo J; David R; Lobach I; Sarpel U Am J Gastroenterol; 2011 Nov; 106(11):1994-2000. PubMed ID: 21912436 [TBL] [Abstract][Full Text] [Related]
15. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India. Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381 [TBL] [Abstract][Full Text] [Related]
16. Systematic review with meta-analysis: development of hepatocellular carcinoma in chronic hepatitis B patients with hepatitis B surface antigen seroclearance. Liu F; Wang XW; Chen L; Hu P; Ren H; Hu HD Aliment Pharmacol Ther; 2016 Jun; 43(12):1253-61. PubMed ID: 27117732 [TBL] [Abstract][Full Text] [Related]
17. What can we learn from hepatitis B virus clinical cohorts? Lin CL; Tseng TC; Kao JH Liver Int; 2015 Jan; 35 Suppl 1():91-9. PubMed ID: 25529093 [TBL] [Abstract][Full Text] [Related]
18. Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study. Marcon PDS; Tovo CV; Kliemann DA; Fisch P; de Mattos AA World J Gastroenterol; 2018 Feb; 24(5):613-622. PubMed ID: 29434450 [TBL] [Abstract][Full Text] [Related]
19. Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma. Chu CM J Gastroenterol Hepatol; 2000 May; 15 Suppl():E25-30. PubMed ID: 10921378 [TBL] [Abstract][Full Text] [Related]
20. Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: a network meta-analysis. Huang ZH; Lu GY; Qiu LX; Zhong GH; Huang Y; Yao XM; Liu XH; Huang SJ; Wu T; Yuan Q; Wang YB; Su YY; Zhang J; Xia NS BMC Cancer; 2022 Mar; 22(1):287. PubMed ID: 35300634 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]